Veeva Systems Inc (VEEV)

298.17 -0.53  -0.18% NYSE Sep 24, 11:06 USD
View Full Chart
Price Chart
View All VEEV News

News

View All Events

Events

Date Type Description
12/01/2021 Earnings Results Q3 2022 Earnings Results
12/01/2021 16:30 EST Earnings Calls Q3 2022 Earnings Call
09/01/2021 Earnings Results Q2 2022 Earnings Results
09/01/2021 17:00 EST Earnings Calls Q2 2022 Earnings Call
06/23/2021 12:00 EST AGM 2021 Annual General Meeting
05/27/2021 Earnings Results Q1 2022 Earnings Results
05/27/2021 17:00 EST Earnings Calls Q1 2022 Earnings Call
03/02/2021 Earnings Results Q4 2021 Earnings Results
03/02/2021 16:30 EST Earnings Calls Q4 2021 Earnings Call
12/01/2020 Earnings Results Q3 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Veeva is a leading supplier of software solutions for the life sciences industry. The company’s best-of-breed offering addresses operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise and cloud-based platform to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning, or ERP, systems that have limited flexibility. As the vertical leader, Veeva innovates, increases wallet share at existing customers, and expands into other industries with similar regulations, protocols, and procedures, such as consumer goods, chemicals, and cosmetics.
  • URL: https://www.veeva.com
  • Investor Relations URL: https://ir.veeva.com/investors/investor-overview/default.aspx
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Health Information Services
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Dec. 01, 2021
  • Last Earnings Release: Sep. 01, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
MSHLX Morgan Stanley Inst Growth L 3.78%
TRUZX T. Rowe Price New Horizons Z 3.33%
BMRRX BlackRock Mid-Cap Growth Equity R 3.19%
ARKG ARK Genomic Revolution ETF 2.82%
FDN First Trust Dow Jones Internet ETF 2.15%
VOT Vanguard Mid-Cap Growth ETF 1.22%
RRMGX T. Rowe Price Mid-Cap Growth R 1.18%
IWP iShares Russell Mid-Cap Growth ETF 0.96%
VIMSX Vanguard Mid Cap Index Investor 0.65%
VO Vanguard Mid-Cap ETF 0.65%
VEXMX Vanguard Extended Market Index Investor 0.58%
VXF Vanguard Extended Market ETF 0.58%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.